Orchestra BioMed Holdings, Inc. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Orchestra BioMed Holdings, Inc. (OBIO) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of -$150.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-01-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2023-01-25
- Orchestra BioMed Holdings, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Orchestra BioMed Holdings, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Orchestra BioMed Holdings, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- Orchestra BioMed Holdings, Inc. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2022-03-31 was -$150.00K, a 600.00% decline year-over-year.
- Orchestra BioMed Holdings, Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2022 was -$150.00K, a 225.00% decline from fiscal 2021.
- Orchestra BioMed Holdings, Inc. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2021 was $120.00K.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-25 | $0.00 derived: sum of 2 quarters · filed 2023-01-25 | $0.00 derived: sum of 3 quarters · filed 2023-01-25 | -$150.00K 10-K · filed 2023-01-25 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | -$150.00K 10-Q · filed 2022-11-14 | -$120.00K derived: sum of 4 quarters · filed 2023-01-25 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | -$150.00K 10-Q · filed 2022-08-15 | -$120.00K derived: sum of 3 quarters · filed 2023-01-25 | -$90.00K derived: sum of 4 quarters · filed 2023-01-25 |
| 2022-03-31 | -$150.00K 10-Q · filed 2022-05-13 | -$120.00K derived: sum of 2 quarters · filed 2023-01-25 | -$90.00K derived: sum of 3 quarters · filed 2023-01-25 | -$60.00K derived: sum of 4 quarters · filed 2023-01-25 |
| 2021-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-01-25 | $60.00K derived: sum of 2 quarters · filed 2023-01-25 | $90.00K derived: sum of 3 quarters · filed 2023-01-25 | $120.00K 10-K · filed 2023-01-25 |
| 2021-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $60.00K derived: sum of 2 quarters · filed 2022-11-14 | $90.00K 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $60.00K 10-Q · filed 2022-08-15 | ||
| 2021-03-31 | $30.00K 10-Q · filed 2022-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |